Fig. 8From: Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcomaMolecular docking results of luteolin and hub targets. (A) Luteolin-AKT1(PDB-ID:7NH5). (B) Luteolin-ALB(PDB-ID:6R7S). (C) Luteolin-CASP3(PDB-ID:7RN7). (D) Luteolin-IL6(PDB-ID:1ALU). (E) Luteolin-JUN (PDB-ID:2P33). (F) Luteolin-STAT3(PDB-ID:6NJS). (G) Luteolin-TNF(PDB-ID:6X81). (H) Luteolin-VEGFA (PDB-ID:1FLT).Back to article page